Join
Live feed
·
INSIDERFilingvia Quantisnow
Ligand Pharmaceuticals Incorporated logo

Chief Financial Officer Espinoza Octavio exercised 2,073 shares at a strike of $63.49 and sold $2,762,822 worth of shares (13,423 units at $205.83), decreasing direct ownership by 34% to 21,662 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.